Propanc Biopharma Implements Reverse Stock Split
Propanc Biopharma says it implemented a reverse stock split to support its Nasdaq listing and growth plans.
Story updates
08:27:24 PM UTC
SquawkNews
Propanc Biopharma, Inc. approved a 1-for-10 reverse stock split, expected effective before market open on Oct. 26, 2026, to support Nasdaq $1.00 minimum bid compliance.Material DetailsContext by AI AnalystThis is a listing-driven corporate action typical for micro-caps facing bid-price deficiencies…
Clears Pathway for Execution of Future R&D Milestone Events such as the Phase 1b, FIH Study for PRP in up to 50 Advanced Cancer Patients with Solid Tumors, First Quarter, 2027MELBOURNE, Australia, Oct. 22, 2026 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today, please no…